CCBR - Buenos Aires - AR

Ciudad Autonoma Buenos Aires C1430CKE

0 studies enrolling now · 3 studies all time

What they study most

Diabetes Mellitus, Type 2, Dyslipidemia, Heart Failure, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed